INVUInvestview Inc

INVU’s stock price is likely driven by revenue growth, profitability trends, and investor confidence in management’s ability to execute a turnaround.

The company reported approximately $2.47 million in total revenue and a net loss of about $3.21 million, so the market may focus heavily on whether losses narrow in upcoming periods.

Because INVU trades on the OTC market and has a small market capitalization of roughly $30.8 million, changes in volume, liquidity, and investor sentiment can create large percentage price moves.

The recent Renu Laboratories acquisition could also influence the stock if investors believe the wellness segment will become revenue accretive as management expects.

Broader trends in retail trading, cryptocurrency interest, direct-to-consumer wellness products, and risk appetite for microcap OTC stocks may also affect valuation.

Investview recently announced that it acquired Renu Laboratories, Inc., a manufacturer of proprietary and third-party health, beauty, skincare, haircare, nutritional supplement, and personal care products.

The acquisition terms were not disclosed, which may make it difficult for investors to immediately judge valuation and deal structure.

Management said the transaction supports a strategy to expand beyond fintech, financial education, blockchain, and digital asset technologies into the health and wellness market.

The company intends to place Renu Labs into a new myLife Wellness business unit and use Investview’s global distribution network and iGenius platform for sales.

Executives stated that the acquisition could become revenue accretive as early as the fourth quarter of 2024 or the first quarter of 2025, but they also acknowledged risks related to integration and execution.

Investview is affected by several broad market trends, including the continued popularity of retail investing, online financial education, and trading communities.

Demand for trading education can rise when markets are volatile, but it can also weaken when retail traders lose interest or face poor performance.

The cryptocurrency and digital asset education market remains cyclical and sensitive to regulation, token prices, and public trust.

The wellness, skincare, and supplement markets are large and growing, but they are also competitive, marketing-intensive, and subject to regulatory scrutiny.

As an OTC microcap, INVU is also influenced by investor appetite for speculative small-cap names, liquidity conditions, and broader risk-on or risk-off market behavior.